Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fine Tuning Antibody Conjugation Methods using SNAP-tag Technology.
Chouman K, Woitok M, Mladenov R, Kessler C, Weinhold E, Hanz G, Fischer R, Meinhold-Heerlein I, Bleilevens A, Gresch G, Haugg AM, Zeppernick F, Bauerschlag D, Maass N, Stickeler E, Kolberg K, Hussain AF. Chouman K, et al. Among authors: hussain af. Anticancer Agents Med Chem. 2017;17(10):1434-1440. doi: 10.2174/1871520617666170213123737. Anticancer Agents Med Chem. 2017. PMID: 28270070
Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model.
Amoury M, Kolberg K, Pham AT, Hristodorov D, Mladenov R, Di Fiore S, Helfrich W, Kiessling F, Fischer R, Pardo A, Thepen T, Hussain AF, Nachreiner T, Barth S. Amoury M, et al. Among authors: hussain af. Cancer Lett. 2016 Mar 28;372(2):201-9. doi: 10.1016/j.canlet.2016.01.027. Epub 2016 Jan 21. Cancer Lett. 2016. PMID: 26806809
A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion protein.
Amoury M, Mladenov R, Nachreiner T, Pham AT, Hristodorov D, Di Fiore S, Helfrich W, Pardo A, Fey G, Schwenkert M, Thepen T, Kiessling F, Hussain AF, Fischer R, Kolberg K, Barth S. Amoury M, et al. Among authors: hussain af. Int J Cancer. 2016 Aug 15;139(4):916-27. doi: 10.1002/ijc.30119. Epub 2016 Apr 15. Int J Cancer. 2016. PMID: 27037627 Free article.
Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand.
Amoury M, Bauerschlag D, Zeppernick F, von Felbert V, Berges N, Di Fiore S, Mintert I, Bleilevens A, Maass N, Bräutigam K, Meinhold-Heerlein I, Stickeler E, Barth S, Fischer R, Hussain AF. Amoury M, et al. Among authors: hussain af. Oncotarget. 2016 Aug 23;7(34):54925-54936. doi: 10.18632/oncotarget.10705. Oncotarget. 2016. PMID: 27448975 Free PMC article.
Detection and Specific Elimination of EGFR+ Ovarian Cancer Cells Using a Near Infrared Photoimmunotheranostic Approach.
Bauerschlag D, Meinhold-Heerlein I, Maass N, Bleilevens A, Bräutigam K, Al Rawashdeh W, Di Fiore S, Haugg AM, Gremse F, Steitz J, Fischer R, Stickeler E, Barth S, Hussain AF. Bauerschlag D, et al. Among authors: hussain af. Pharm Res. 2017 Apr;34(4):696-703. doi: 10.1007/s11095-017-2096-4. Epub 2017 Jan 10. Pharm Res. 2017. PMID: 28074431
Simultaneous and Independent Dual Site-Specific Self-Labeling of Recombinant Antibodies.
Wollschlaeger C, Meinhold-Heerlein I, Cong X, Bräutigam K, Di Fiore S, Zeppernick F, Klockenbring T, Stickeler E, Barth S, Hussain AF. Wollschlaeger C, et al. Among authors: hussain af. Bioconjug Chem. 2018 Nov 21;29(11):3586-3594. doi: 10.1021/acs.bioconjchem.8b00545. Epub 2018 Oct 17. Bioconjug Chem. 2018. PMID: 30289242
Elimination of HER3-expressing breast cancer cells using aptamer-siRNA chimeras.
Nachreiner I, Hussain AF, Wullner U, Machuy N, Meyer TF, Fischer R, Gattenlöhner S, Meinhold-Heerlein I, Barth S, Tur MK. Nachreiner I, et al. Among authors: hussain af. Exp Ther Med. 2019 Oct;18(4):2401-2412. doi: 10.3892/etm.2019.7753. Epub 2019 Jul 9. Exp Ther Med. 2019. PMID: 31555351 Free PMC article.
29 results